Withdrawal indicators arise in infants born to moms who receive barbiturates all through the past trimester of pregnancypentobarbital will minimize the extent or outcome of ondansetron by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor. No dosage adjustment for ondansetron is usually recommended for individuals on these d